Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome

Introduction: Metabolic syndrome includes insulin resistance, visceral obesity, hypertension and dyslipidemia, which together lead to an increased risk of atherosclerosis, cardiovascular diseases, and diabetes mellitus. Insulin resistance is considered a pathophysiological mechanism underlying metab...

Full description

Bibliographic Details
Main Authors: Mitrović Marija, Mišević Vojko, Popović Ljiljana
Format: Article
Language:English
Published: University of Belgrade, Medical Faculty 2023-01-01
Series:Medicinski Podmladak
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2023/0369-15272303058M.pdf
_version_ 1827589082660732928
author Mitrović Marija
Mišević Vojko
Popović Ljiljana
author_facet Mitrović Marija
Mišević Vojko
Popović Ljiljana
author_sort Mitrović Marija
collection DOAJ
description Introduction: Metabolic syndrome includes insulin resistance, visceral obesity, hypertension and dyslipidemia, which together lead to an increased risk of atherosclerosis, cardiovascular diseases, and diabetes mellitus. Insulin resistance is considered a pathophysiological mechanism underlying metabolic syndrome, characterized by inadequate glucose metabolism, hyperinsulinemia and lipid imbalance. Non-alcoholic fatty liver disease is a chronic disease characterized by microvesicular steatosis and isn't a consequence of the use of drugs, alcohol, or inherited diseases and is a hepatic manifestation of metabolic syndrome. Aim: Since insulin resistance is pathophysiologically related to metabolic liver diseases, the aim of this study was to investigate the correlation of the FLI index with insulin resistance indices HOMA and QUICKI, but also a comparison of the insulin resistance index HOMA, Quicki and Tyg and the FLI index of fatty liver in the complete sample and in the groups of overweight and obese patients with characteristics of the metabolic syndrome. Material and methods: The study included 70 patients who met the criteria for the diagnosis of metabolic syndrome and who were selected by reviewing the medical documentation. Patients were divided into two groups. Group A were overweight patients (BMI 25 - 29.9 kg/m2). Group B were obese patients (BMI > 30 kg/m2). Insulin resistance index values were compared between groups and then correlated by statistical analysis with FLI index within groups and in a complete sample. Results: Statistical analysis found a correlation between the FLI index and the insulin resistance index HOMA (p = 0.03) in a complete sample. A statistically significant difference in the values of the FLI index between the examined groups was proved (p = 0.001). Conclusion: The positive correlation between the FLI index with the HOMA index speaks in favor of the interrelationship between insulin resistance and fatty liver in patients with metabolic syndrome. In this case, insulin resistance can be a predictor for the development of non-alcoholic fatty liver disease, steatosis, steatohepatitis, hepatocellular carcinoma and cardiovascular diseases.
first_indexed 2024-03-09T00:49:37Z
format Article
id doaj.art-76067bdf3684442d8b16326833e878a7
institution Directory Open Access Journal
issn 0369-1527
2466-5525
language English
last_indexed 2024-03-09T00:49:37Z
publishDate 2023-01-01
publisher University of Belgrade, Medical Faculty
record_format Article
series Medicinski Podmladak
spelling doaj.art-76067bdf3684442d8b16326833e878a72023-12-11T17:19:05ZengUniversity of Belgrade, Medical FacultyMedicinski Podmladak0369-15272466-55252023-01-01743586310.5937/mp74-404160369-15272303058MCorrelation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndromeMitrović Marija0Mišević Vojko1Popović Ljiljana2Univerzitet u Beogradu, Medicinski fakultet, Beograd, SerbiaUniverzitet u Beogradu, Medicinski fakultet, Beograd, SerbiaUniverzitet u Beogradu, Medicinski fakultet, Beograd, SerbiaIntroduction: Metabolic syndrome includes insulin resistance, visceral obesity, hypertension and dyslipidemia, which together lead to an increased risk of atherosclerosis, cardiovascular diseases, and diabetes mellitus. Insulin resistance is considered a pathophysiological mechanism underlying metabolic syndrome, characterized by inadequate glucose metabolism, hyperinsulinemia and lipid imbalance. Non-alcoholic fatty liver disease is a chronic disease characterized by microvesicular steatosis and isn't a consequence of the use of drugs, alcohol, or inherited diseases and is a hepatic manifestation of metabolic syndrome. Aim: Since insulin resistance is pathophysiologically related to metabolic liver diseases, the aim of this study was to investigate the correlation of the FLI index with insulin resistance indices HOMA and QUICKI, but also a comparison of the insulin resistance index HOMA, Quicki and Tyg and the FLI index of fatty liver in the complete sample and in the groups of overweight and obese patients with characteristics of the metabolic syndrome. Material and methods: The study included 70 patients who met the criteria for the diagnosis of metabolic syndrome and who were selected by reviewing the medical documentation. Patients were divided into two groups. Group A were overweight patients (BMI 25 - 29.9 kg/m2). Group B were obese patients (BMI > 30 kg/m2). Insulin resistance index values were compared between groups and then correlated by statistical analysis with FLI index within groups and in a complete sample. Results: Statistical analysis found a correlation between the FLI index and the insulin resistance index HOMA (p = 0.03) in a complete sample. A statistically significant difference in the values of the FLI index between the examined groups was proved (p = 0.001). Conclusion: The positive correlation between the FLI index with the HOMA index speaks in favor of the interrelationship between insulin resistance and fatty liver in patients with metabolic syndrome. In this case, insulin resistance can be a predictor for the development of non-alcoholic fatty liver disease, steatosis, steatohepatitis, hepatocellular carcinoma and cardiovascular diseases.https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2023/0369-15272303058M.pdfmetabolic syndromeinsulin resistancefli index
spellingShingle Mitrović Marija
Mišević Vojko
Popović Ljiljana
Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome
Medicinski Podmladak
metabolic syndrome
insulin resistance
fli index
title Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome
title_full Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome
title_fullStr Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome
title_full_unstemmed Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome
title_short Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome
title_sort correlation of fli fatty liver index with insulin resistance indices in patients with metabolic syndrome
topic metabolic syndrome
insulin resistance
fli index
url https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2023/0369-15272303058M.pdf
work_keys_str_mv AT mitrovicmarija correlationofflifattyliverindexwithinsulinresistanceindicesinpatientswithmetabolicsyndrome
AT misevicvojko correlationofflifattyliverindexwithinsulinresistanceindicesinpatientswithmetabolicsyndrome
AT popovicljiljana correlationofflifattyliverindexwithinsulinresistanceindicesinpatientswithmetabolicsyndrome